Align Technology ALGN

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$1.85 (+1.08%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Align Technology (ALGN)
    Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $173.75

    • Market Cap

      $12.79 Billion

    • Price-Earnings Ratio

      29.65

    • Total Outstanding Shares

      73.60 Million Shares

    • Total Employees

      20,945

    • Dividend

      No dividend

    • IPO Date

      January 26, 2001

    • SIC Description

      Orthopedic, Prosthetic & Surgical Appliances & Supplies

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      410 north scottsdale road, suite 1300, Tempe, AZ, 85288

    • Homepage

      https://www.aligntech.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow From Investing Activities$-214.32 Million
    Net Cash Flow From Investing Activities, Continuing$-214.32 Million
    Net Cash Flow, Continuing$-218.25 Million
    Exchange Gains/Losses$21.88 Million
    Net Cash Flow From Financing Activities, Continuing$-502.98 Million
    Net Cash Flow$-196.37 Million

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Cost Of Revenue$1.19 Billion
    Diluted Earnings Per Share$5.86
    Revenues$3.96 Billion
    Income Tax Expense/Benefit, Deferred$21.57 Million
    Operating Expenses$2.14 Billion
    Basic Average Shares$149.67 Million

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss$475.44 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss Attributable To Parent$475.44 Million
    Other Comprehensive Income/Loss$475.44 Million
    Other Comprehensive Income/Loss Attributable To Parent$33.87 Million

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Prepaid Expenses$72.98 Million
    Liabilities$2.42 Billion
    Other Non-current Assets$2.36 Billion
    Equity Attributable To Parent$3.94 Billion
    Equity$3.94 Billion
    Noncurrent Assets$3.77 Billion

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ALGN from trusted financial sources

      Related Companies

      Additional publicly traded companies similar to Align Technology (ALGN)
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.